Filariasis Clinical Trials This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

• News
• Research
• Blogs
• Podcasts
• Clinical Trials
• Forums

Safety, Tolerability and PK of Multiple-ascending Doses of Emodepside
Condition:   Filariasis Intervention:   Drug: LSF emodepside (BAY 44-4400) oral solution (1mg/mL) Sponsors:   Drugs for Neglected Diseases;   Bayer;   Bill and Melinda Gates Foundation Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 25, 2017 Category: Research Source Type: clinical trials

Relative Bioavailability Study of Emodepside IR-tablets and Solution
Condition:   Filariasis Intervention:   Drug: Emodepside (BAY 44-4400) Sponsors:   Drugs for Neglected Diseases;   Bayer;   Bill and Melinda Gates Foundation Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 25, 2017 Category: Research Source Type: clinical trials

Safety, Tolerability and PK of Multiple-ascending Doses of Emodepside
Condition:   Filariasis Intervention:   Drug: LSF emodepside (BAY 44-4400) oral solution (1mg/mL) Sponsors:   Drugs for Neglected Diseases;   Bayer;   Bill and Melinda Gates Foundation Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 25, 2017 Category: Research Source Type: clinical trials

Relative Bioavailability Study of Emodepside IR-tablets and Solution
Condition:   Filariasis Intervention:   Drug: Emodepside (BAY 44-4400) Sponsors:   Drugs for Neglected Diseases;   Bayer;   Bill and Melinda Gates Foundation Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 25, 2017 Category: Research Source Type: clinical trials

Safety, Tolerability and PK of Multiple-ascending Doses of Emodepside
Condition:   Filariasis Intervention:   Drug: LSF emodepside (BAY 44-4400) oral solution (1mg/mL) Sponsors:   Drugs for Neglected Diseases;   Bayer;   Bill and Melinda Gates Foundation Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 25, 2017 Category: Research Source Type: clinical trials

Relative Bioavailability Study of Emodepside IR-tablets and Solution
Condition:   Filariasis Intervention:   Drug: Emodepside (BAY 44-4400) Sponsors:   Drugs for Neglected Diseases;   Bayer;   Bill and Melinda Gates Foundation Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 25, 2017 Category: Research Source Type: clinical trials

Safety, Tolerability and PK of Multiple-ascending Doses of Emodepside
Condition:   Filariasis Intervention:   Drug: LSF emodepside (BAY 44-4400) oral solution (1mg/mL) Sponsors:   Drugs for Neglected Diseases;   Bayer;   Bill and Melinda Gates Foundation Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 25, 2017 Category: Research Source Type: clinical trials

Relative Bioavailability Study of Emodepside IR-tablets and Solution
Condition:   Filariasis Intervention:   Drug: Emodepside (BAY 44-4400) Sponsors:   Drugs for Neglected Diseases;   Bayer;   Bill and Melinda Gates Foundation Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 25, 2017 Category: Research Source Type: clinical trials

Safety, Tolerability and PK of Multiple-ascending Doses of Emodepside
Condition:   Filariasis Intervention:   Drug: LSF emodepside (BAY 44-4400) oral solution (1mg/mL) Sponsors:   Drugs for Neglected Diseases;   Bayer;   Bill and Melinda Gates Foundation Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 25, 2017 Category: Research Source Type: clinical trials

Relative Bioavailability Study of Emodepside IR-tablets and Solution
Condition:   Filariasis Intervention:   Drug: Emodepside (BAY 44-4400) Sponsors:   Drugs for Neglected Diseases;   Bayer;   Bill and Melinda Gates Foundation Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 25, 2017 Category: Research Source Type: clinical trials

Safety, Tolerability and PK of Multiple-ascending Doses of Emodepside
Condition:   Filariasis Intervention:   Drug: LSF emodepside (BAY 44-4400) oral solution (1mg/mL) Sponsors:   Drugs for Neglected Diseases;   Bayer;   Bill and Melinda Gates Foundation Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 25, 2017 Category: Research Source Type: clinical trials